Brandinium

Trademark search for:

CHARACTERIZED IMMUNOTHERAPY

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2013-05-13 — Application filed
  • 2013-05-16 — Application filed
  • 2013-05-23 — Application filed
  • 2013-08-29 — Final disposition recorded
  • 2013-08-29 — Final disposition recorded
  • 2013-08-29 — Assigned to examiner
  • 2013-08-29 — Final disposition recorded
  • 2013-11-07 — Office action issued
  • 2013-11-12 — Assigned to lie
  • 2013-11-19 — Teas/email correspondence entered
  • 2013-11-19 — Correspondence received in law office
  • 2013-12-02 — Approved for pub - principal register
  • 2013-12-05 — Law office publication review completed
  • 2013-12-15 — Withdrawn from pub - og review query
  • 2014-01-29 — Notification of notice of publication e-mailed
  • 2014-02-18 — Published for opposition
  • 2014-02-18 — Official gazette publication confirmation e-mailed
  • 2014-04-15 — Noa e-mailed - sou required from applicant
  • 2014-07-09 — Attorney/dom.rep.revoked and/or appointed
  • 2014-07-09 — Teas revoke/app/change addr of atty/dom rep received
  • 2014-09-12 — Attorney/dom.rep.revoked and/or appointed
  • 2014-09-12 — Teas revoke/app/change addr of atty/dom rep received
  • 2014-10-07 — Sou teas extension received
  • 2014-10-07 — Sou extension 1 filed
  • 2014-10-23 — Case assigned to intent to use paralegal
  • 2014-10-24 — Sou extension 1 granted
  • 2014-10-25 — Notice of approval of extension request e-mailed
  • 2014-12-03 — Teas statement of use received
  • 2014-12-03 — Use amendment filed
  • 2014-12-11 — Statement of use processing complete
  • 2014-12-13 — Allowed principal register - sou accepted
  • 2014-12-16 — Notice of acceptance of statement of use e-mailed
  • 2015-01-20 — Teas change of owner address received
  • 2015-01-20 — Registered-principal register
  • 2015-01-20 — Applicant/correspondence changes (non-responsive) entered
  • 2015-08-12 — Automatic update of assignment of ownership
  • 2018-06-14 — Attorney/dom.rep.revoked and/or appointed
  • 2018-06-14 — Teas revoke/app/change addr of atty/dom rep received
  • 2020-01-20 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2020-10-28 — Assignment of ownership not updated automatically
  • 2021-08-27 — Cancelled sec. 8 (6-yr)
  • 2021-08-27 — Final status recorded
  • 2021-10-13 — Automatic update of assignment of ownership

Owner Information

SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
VEVEY CH
AIMMUNE THERAPEUTICS, INC.
BRISBANE , CA
Allergen Research Corporation
San Mateo , CA
Allergen Research Corporation
Menlo Park , CA
Allergen Research Corporation
Menlo Park , CA

Correspondent

Thad Chaloemtiarana PATTISHALL, MCAULIFFE, NEWBURY, HILLIARD & GERALDS
200 South Wacker Drive, Suite 2900
CHICAGO, IL 60606-5896
UNITED STATES

Filing Details

Filing Date:
2013-05-13
Status Date:
2021-08-27
Category:
Pharmaceuticals
Filing Year:
2013

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.